HIGH-FIELD, SITE-SPECIFIC COUPLING OF N-TERMINALLY MODIFIED BETA-LACTAMASE TO A PROTEOLYTICALLY DERIVED SINGLE-SULFHYDRYL MURINE FAB'

被引:31
作者
MIKOLAJCZYK, SD
MEYER, DL
STARLING, JJ
LAW, KL
ROSE, K
DUFOUR, B
OFFORD, RE
机构
[1] ELI LILLY & CO,LILLY RES LABS,INDIANAPOLIS,IN 46285
[2] CTR MED UNIV GENEVA,DEPT BIOCHIM MED,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
10.1021/bc00030a020
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The preparation of bispecific protein conjugates capable of performing diverse biological functions is an area of active investigation. Such conjugates are routinely prepared using techniques which employ random derivatization of lysine residues, but the overall utility of these methods is limited due to poor yields and heterogeneous conjugates. In this report we describe the development of site-specific linkage methodology for the chemical synthesis of a homogeneous enzyme-antibody Fab' conjugate with coupling efficiencies of at least 72%. The N-terminal threonine residue of beta-lactamase from the P99 strain of Enterobacter cloacae was oxidized to an aldehyde functional group under mild conditions with a 5-fold molar excess of sodium periodate. The murine Fab' with a single sulfhydryl at the hinge region was generated by further digestion of the peptic Fab' fragment with lysyl endopeptidase to remove a decapeptide containing two of the three cysteine residues. Coupling of the two modified proteins was accomplished through a bifunctional coupling reagent containing maleimide and aminooxy functional groups. Synthesis of the linker is described. Yields of 1:1 enzyme-Fab' were at least three times higher than for comparable random derivatization methods. Immunoreactivity and enzymatic activity were unaffected. Biodistribution studies showed a more favorable tumor to blood ratio with the site-specifically linked conjugate.
引用
收藏
页码:636 / 646
页数:11
相关论文
共 41 条
[1]   MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF A FUSION PROTEIN SUITED FOR TUMOR SPECIFIC PRODRUG ACTIVATION [J].
BOSSLET, K ;
CZECH, J ;
LORENZ, P ;
SEDLACEK, HH ;
SCHUERMANN, M ;
SEEMANN, G .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :234-238
[2]  
BUCHEGGER F, 1983, J EXP MED, V158, P413, DOI 10.1084/jem.158.2.413
[3]   PURIFICATION OF BETA-LACTAMASES BY AFFINITY-CHROMATOGRAPHY ON PHENYLBORONIC ACID AGAROSE [J].
CARTWRIGHT, SJ ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1984, 221 (02) :505-512
[4]   A RAPID METHOD OF CLONING FUNCTIONAL VARIABLE-REGION ANTIBODY GENES IN ESCHERICHIA-COLI AS SINGLE-CHAIN IMMUNOTOXINS [J].
CHAUDHARY, VK ;
BATRA, JK ;
GALLO, MG ;
WILLINGHAM, MC ;
FITZGERALD, DJ ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :1066-1070
[5]   INVIVO TUMOR TARGETING OF A RECOMBINANT SINGLE-CHAIN ANTIGEN-BINDING PROTEIN [J].
COLCHER, D ;
BIRD, R ;
ROSELLI, M ;
HARDMAN, KD ;
JOHNSON, S ;
POPE, S ;
DODD, SW ;
PANTOLIANO, MW ;
MILENIC, DE ;
SCHLOM, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14) :1191-1197
[6]  
Dixon H B, 1972, Methods Enzymol, V25, P409, DOI 10.1016/S0076-6879(72)25036-4
[7]  
FAGNANI R, 1990, CANCER RES, V50, P3638
[8]   A SPECTROPHOTOMETRIC METHOD FOR MICRODETERMINATION OF PERIODATE [J].
FIELDS, R ;
DIXON, HBF .
BIOCHEMICAL JOURNAL, 1968, 108 (05) :883-&
[9]   SITE-SPECIFIC MODIFICATION OF A FRAGMENT OF A CHIMERIC MONOCLONAL-ANTIBODY USING REVERSE PROTEOLYSIS [J].
FISCH, I ;
KUNZI, G ;
ROSE, K ;
OFFORD, RE .
BIOCONJUGATE CHEMISTRY, 1992, 3 (02) :147-153
[10]  
FISCH I, 1993, THESIS U GENEVA